The 20 Best Thyroid Cancer Doctors Near Me
Find Doctors who have experience with Sorafenib
Office
Steven Waguespack is an Endocrinologist practicing medicine in Houston, Texas. Dr. Waguespack is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia, Thyroidectomy, and Parathyroidectomy. Dr. Waguespack is currently accepting new patients.
City Of Hope Comprehensive Cancer Center-Duarte
Sumanta Pal is an Oncologist practicing medicine in Duarte, California. Dr. Pal is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Bladder Cancer, Nephrectomy, and Lymphadenectomy.
UT MD Anderson Cancer Center
Ramona Dadu is an Endocrinologist practicing medicine in Cary, North Carolina. Dr. Dadu is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Anaplastic Thyroid Cancer, Thyroid Cancer, Medullary Thyroid Carcinoma, Papillary Thyroid Cancer, and Thyroidectomy. Dr. Dadu is currently accepting new patients.
Are you looking for a specific type of Thyroid Cancer?
Common conditions include: Anaplastic Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer
Skip Viragh Outpatient Cancer Center
Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Carducci is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Carducci is board certified in American Board Of Internal Medicine. Dr. Carducci is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Colonoscopy. Dr. Azad is board certified in American Board Of Internal Medicine. Dr. Azad is currently accepting new patients.
Jefferson Torresdale Hospital
Marcia Brose is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Brose is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Medullary Thyroid Carcinoma, Papillary Thyroid Cancer, and Anaplastic Thyroid Cancer. Dr. Brose is board certified in Medical Oncology. Dr. Brose is currently accepting new patients.
UT MD Anderson Cancer Center
Naifa Busaidy is an Endocrinologist practicing medicine in Houston, Texas. Dr. Busaidy is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroidectomy, and Parathyroidectomy. Dr. Busaidy is currently accepting new patients.
UT MD Anderson Cancer Center
Mouhammed Habra is an Endocrinologist practicing medicine in Houston, Texas. Dr. Habra is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Adrenocortical Carcinoma, Adrenal Cancer, Thyroid Cancer, Tissue Biopsy, and Thyroidectomy. Dr. Habra is currently accepting new patients.
Office
Maria Cabanillas is an Endocrinologist practicing medicine in Houston, Texas. Dr. Cabanillas is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Anaplastic Thyroid Cancer, Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroidectomy, and Tissue Biopsy. Dr. Cabanillas is currently accepting new patients.
Antonio Gasbarrini practices practicing medicine in Rome, Italy. Gasbarrini is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. They are also highly rated in 70 other conditions, according to our data. Their clinical expertise encompasses Small Bowel Bacterial Overgrowth, Viral Gastroenteritis, Helicobacter Pylori Infection, Liver Transplant, and Endoscopy.
Stefan Zeuzem practices practicing medicine in Frankfurt Am Main, Germany. Mr. Zeuzem is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, Cirrhosis, Liver Transplant, and Gastrostomy.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology. Dr. Worden is currently accepting new patients.
Jaume Capdevila practices practicing medicine in Barcelona, Spain. Capdevila is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. They are also highly rated in 15 other conditions, according to our data. Their clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Thyroid Cancer, and Medullary Thyroid Carcinoma.
Yale New Haven Hospital
Harriet Kluger is an Oncologist practicing medicine in New Haven, Connecticut. Dr. Kluger is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Renal Cell Carcinoma (RCC), Metastatic Brain Tumor, and Nephrectomy.
Antongiulio Faggiano practices practicing medicine in Rome, Italy. Faggiano is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. They are also highly rated in 27 other conditions, according to our data. Their clinical expertise encompasses Neuroendocrine Tumor, Multiple Endocrine Neoplasia, Multiple Endocrine Neoplasia Type 1, Parathyroidectomy, and Thyroidectomy.
Jie Liu practices practicing medicine in Zhengzhou, China. Mr. Liu is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. He is also highly rated in 256 other conditions, according to our data. His clinical expertise encompasses Cerebral Hypoxia, Liver Cancer, Lung Cancer, Endoscopy, and Thyroidectomy.
UT MD Anderson Cancer Center
Filip Janku is an Oncologist practicing medicine in Cary, North Carolina. Dr. Janku is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Adult Soft Tissue Sarcoma, Colorectal Cancer, Gastrointestinal Stromal Tumor, and Tissue Biopsy.
Clinical Cancer Center - Froedtert Hospital
Dr. Kurzrock is a world-renowned leader in precision oncology and rare cancers research. She is the Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center, Associate Director of Precision Oncology at the Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine and the founding director of the Michels Rare Cancers Research Laboratories at the MCW Cancer Center. She is recognized as one of the world’s 25 most important voices in precision medicine and one of the most highly cited scientists globally. She has authored over 950 scientific and medical publications. Dr. Kurzrock is the Chair for the Early Therapeutics and Rare Cancers Committee (SWOG NCI) — one of the largest clinical trials cooperative groups in the country — and has been the principal investigator for more than 100 early-phase clinical trials, leading eight life-changing drugs to FDA approval. In 2022, Dr. Kurzrock and the DART rare cancer study team received the National Cancer Institute Director’s Award of Merit for outstanding work. Dr. Kurzrock is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Castleman Disease, Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, and Tissue Biopsy. Dr. Kurzrock is board certified in Internal Medicine and Medical Oncology. Dr. Kurzrock is currently accepting new patients.
Gustave Roussy
Jean-charles Soria practices practicing medicine in Villejuif, France. Soria is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. They are also highly rated in 15 other conditions, according to our data. Their clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy.
Gustave Roussy
Antoine Italiano practices practicing medicine in Villejuif, France. Mr. Italiano is rated as an Elite expert by MediFind in the treatment of Thyroid Cancer. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, Tissue Biopsy, and Hysterectomy.
Last Updated: 09/26/2026










